Vascular & Endovascular

The Eluvia drug-eluting vascular stent system has been approved by the FDA, device maker Boston Scientific announced Sept. 24—just two days after results from the IMPERIAL trial were presented at the Transcatheter Cardiovascular Therapeutics 2018 meeting.
Height—and the genes that influence it—are important predictors for the development of varicose veins, according to a study out of Stanford University.
Resolute Onyx, a polymer-coated zotarolimus-eluting stent, has been proven safe and effective in an all-comer population of more than 2,000 heart patients, according to late-breaking results of the BIONYX trial.
Atrial fibrillation patients are acutely aware of their five-fold increased risk of stroke, new research from StopAfib.org suggests—and 38 percent report feeling “trapped” between their fear of having a stroke and the major bleeding risks associated with anticoagulants.
Patients who suffer from deep vein thrombosis (DVT) see a “clear benefit” from initiating preventive compression therapy shortly after their diagnosis, as opposed to later stages of treatment, according to a study published this week in the journal Blood.
Risk-adjustment models assessing hospitals’ stroke outcomes should include patient transfer status, argue the authors of a new study, who found centers that accepted more transfer patients treated a sicker population and experienced higher mortality rates.
Women who most closely adhere to a Mediterranean-style diet could be lowering their risk of stroke by up to 22 percent, according to 17-year results of a large-scale study out of the United Kingdom.
A recent meta-analysis published in Circulation: Cardiovascular Quality and Outcomes suggests the benefit of anticoagulation for pulmonary arterial hypertension (PAH) may depend on the subtype of the condition. Mortality rates improved with anticoagulation for patients with idiopathic PAH but worsened for those with scleroderma-associated PAH.
A New Jersey hospital is testing an artificial intelligence (AI) device designed to alert clinicians to bleeding episodes during endovascular procedures.
The FDA has approved Contego Medical’s Paladain Carotid PTA Balloon System, the first approved embolic protection device to contain both a carotid angioplasty balloon and an integrated filter.
A daily, low dose of aspirin isn’t preventive against early death or disability in older patients who are otherwise healthy, according to results from the eight-year ASPREE trial that were released Sept. 16.
Optimal candidates for a switch from vitamin K antagonists like warfarin to direct oral anticoagulants (DOACs) have long been identified by a single statistic—time-in-therapeutic range—but a recent Danish analysis of anticoagulants in atrial fibrillation patients suggests the marker might be less insightful than previously thought.
Cerner and Duke Clinical Research Institute have teamed up to develop a new CVD risk calculator app, the companies announced late this summer—a move they hope will improve shared decision-making between physicians and their patients.
French pharmaceutical company Servier has partnered with Bioserenity to launch a “smart T-shirt” they’re calling the Cardioskin—a wearable innovation that would allow heart patients to monitor their cardiac rhythm throughout the day, the Daily Mail has reported.
Certain characteristics predict how responsive a blood clot will be to intravenous alteplase, according to research published Sept. 11 in JAMA—knowledge that may help clinicians more efficiently triage patients with acute ischemic stroke.
Exposure to fluoroquinolones—one of the most popular classes of antibiotics in the world—is associated with more than double the risk of aortic aneurysm or aortic dissection, according to a study published online in the Journal of the American College of Cardiology.
Vascular & Endovascular
Sep 12, 2018 | Lipids & Metabolic
Consuming three or more servings of whole-fat dairy per day—especially in developing countries—has been linked to lower rates of cardiovascular disease, according to research published Sept. 11 in the Lancet.
Lipids & Metabolic, Vascular & Endovascular
Patients with sepsis are at a greater risk for heart attack and stroke in the four weeks following hospital discharge, research out of Taiwan has found, with more than half of all adverse CVD events in the ensuing six months occurring within 35 days of leaving the hospital. 
Acute Coronary Syndrome, Vascular & Endovascular
Sep 10, 2018 | Hypertension
Swapping singular blood pressure measurements for long-term, cumulative ones could improve CVD risk prediction models, Northwestern University researchers report in the current online edition of JAMA Cardiology.
Hypertension, Vascular & Endovascular
A peer-reviewed study published in Clinical Toxicology this week warns competitive athletes—and cardiac patients—against consuming supplements that might contain higenamine, a stimulant that’s poorly regulated and could pose a considerable threat to heart health.
Vascular & Endovascular
Researchers at Michigan Medicine in Ann Arbor are funneling an estimated $45 million into a randomized controlled trial they hope will clarify the link between stroke and obstructive sleep apnea.
Vascular & Endovascular